Narayan Nair MD
Division Director, Division of Pharmacovigilance, CBER, FDA
Join to View Full Profile
10903 New Hampshire AvenueSilver Spring, MD 20993
Dr. Nair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Wright-Patterson Medical CenterResidency, Internal Medicine, 1994 - 1997
Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1994- Saint Louis UniversityB.S., Biology
Certifications & Licensure
PA State Medical License 1997 - 2026
OH State Medical License 1996 - 1998
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS).Mayra Oliveira, Paige Marquez, Carol Ennulat, Phillip Blanc, Kerry Welsh
Drug Safety. 2025-03-01 - Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccinati...Supriya S Jain, Steven A Anderson, Jeremy M Steele, Hunter C Wilson, Juan Carlos Muniz
Eclinicalmedicine. 2024-10-01 - Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years - United States, July 13, 2022-March 13, 2023.Brittney Romanson, Pedro L Moro, John R Su, Paige Marquez, Narayan Nair
MMWR. Morbidity and Mortality Weekly Report. 2023-08-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
